On August 28, 2025 Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, reported that Paul Peter Tak, M.D., Ph.D., FMedSci, Candel’s President and Chief Executive Officer, will participate in upcoming investor conferences with associated one-on-one investor meetings (Press release, Candel Therapeutics, AUG 28, 2025, View Source [SID1234655560]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Citi’s 2025 Biopharma Back to School Conference (Boston, MA)
Date/Time: Wednesday, September 3, 2025, at 9:00 AM ET
Webcast Link: Citi / Candel Fireside Chat

Cantor Global Healthcare Conference (New York, NY)
Date/Time: Thursday, September 4, 2025, at 8:00 AM ET
Webcast Link: Cantor / Candel Fireside Chat

H.C. Wainwright 27th Annual Global Investment Conference (New York, NY)
Date/Time: Friday, September 5, 2025, at 7:00 AM ET
Webcast Link: H.C. Wainwright / Candel Presentation

Live webcasts of the presentations will be available by selecting Events and Presentations under the News & Events tab in the Investors section on www.candeltx.com. A replay of the webcasts will be archived for up to 90 days following the session date.